Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 54.74

-2.1%

Dec 17 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: seminole who wrote (5539)	1/24/2002 6:15:36 PM
From: Biomaven	Read Replies (1) of 52153

Hi Richard - Any news from the front? I still have some MOGN shares from way back, but haven't kept track of the Yahoo board. The stock has been doing pretty well. The pancreatic Ph III should conclude this year, right? I've always believed Irofulven is going to be an approvable drug. I think Miljenko has always disagreed with me on this one. <g> You have any comment on MOGN's methyltransferase stuff? I realize you may not be able to comment much on Irofulven. Peter

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next